Welcome to our team page!
I have been successfully fighting Multiple Myeloma for 4.5 years. It has not been easy, but each one of you have brought me love and support. I appreciate you so much! I know I could not have done it without your support. Asking again for your support in monetary terms to give to the researchers at Fred Hutch. I believe there will be a cure in my lifetime, but they need all that we can give to keep going. I hope I am physically fit enough to receive the treatment. Each relapse leaves you less physically and biologically able to defend yourself against the side effects of the treatment of the previous treatment. Thank you for your unwavering support!
Our team is participating in the 2025 Defeat Multiple Myeloma Run/Walk on Sunday, June 29. Each member of this team plays a part in bringing myeloma treatment options to patients faster and helping fund research to find a cure for this cancer. Together, we are building community, supporting survivors, remembering loved ones lost, and funding research that is giving new hope to patients. We are committed, we are strong, and our impact can be enormous.
Please join us in this fight and increase our impact by making a donation to our team today; 100% of all funds raised will go directly to advancing multiple myeloma cancer research at Fred Hutchinson Cancer Research Center.
What is Multiple Myeloma?
Multiple Myeloma is a cancer of plasma cells found in bone marrow. Normal plasma cells help the immune system fight disease, but when plasma cells become cancerous they grow out of control and can produce a tumor called a plasmacytoma. If someone has more than one plasmacytoma, they have multiple myeloma.
Why support this event?
Defeat Multiple Myeloma’s mission is to raise awareness of multiple myeloma while supporting research that seeks to discover new treatments, improve the quality of life for myeloma patients, and ultimately find a cure for this devastating form of cancer. Funds from the 2025 Defeat Multiple Myeloma event will continue to support immunotherapy research and clinical trials at Fred Hutch which are using CAR-T cells and have shown very promising early results for patients.
